This book is an exploration into ethical tensions that new technology creates, with a particular focus on agricultural biotechnology and genetically modified (GM) food. There are four main arenas where new technologies generally, and agricultural biotechnology in particular, create ethical...

The normative research question addressed in this chapter is whether the public interest means agricultural biotechnology should lead (and thus reshape) public opinion or wait for public opinion to become sufficiently supportive. The chapter considers three models of how public opinion is linked to ...

This chapter explores the ethical implications of genetically modified organisms (GMOs) in food that originate from plants genetically altered through bioengineering. The chapter analyses the new federal statute recently passed in the USA purportedly to label these foods and evaluates whether in...

This chapter uses the USA and India as case examples to analyse how ethical tensions arise related to agricultural biotechnology policy and how institutional framework and domestic politics address these ethical tensions and contribute to divergence in regulatory policy outcomes. It is shown, for...

This chapter discusses the domestication and conventional breeding of animals; biotechnology definitions and methods; effects of biotechnology procedures on animal welfare; effects of cloning procedures on animal welfare; effects of genetic modification procedures on animal welfare; genetic...

This chapter indicates that the political economy of the bioeconomy is emerging as one of the most focused economic research areas applied to the bioeconomy, given the high degree of uncertainty over bioeconomy technologies, the diverse interests and political positions of stakeholders, together...

This chapter focuses on Canada's novel approach to GM regulations. It discusses the recently adopted Agricultural Growth Act (AGA) which amends several key aspects of the Seeds Act and the Plant Breeders' Rights Act. The implications of AGA for intellectual property rights (IPRs), seed ownership...

This chapter defines biosimilars/biogenerics and discusses the importance of biotherapeutics in healthcare. The intellectual property rights issues, the resolution of patent disputes, new intellectual property challenges, regulatory issues and guidelines are discussed. The nomenclature of...

This chapter highlights patent issues over drug research innovation related to technological regulations, public health and harnessing the health benefits of natural compounds for drug development, with special context to India. The biotechnology patent scenario and the synthetic drugs and natural...

This chapter summarizes the research developed during the last century on different aspects of the red palm weevil R. ferrugineus, including latest findings on its biology, morphotaxonomy, geographical distribution, economic impact and management and prevention options, including chemical,...